Single-agent dabrafenib for BRAFV600E-mutated histiocytosis

被引：36

作者：

Bhatia, Ankush ^{[1
]}

Ulaner, Gary ^{[2
]}

Rampal, Raajit ^{[3
]}

Hyman, David M. ^{[3
]}

Abdel-Wahab, Omar ^{[3
]}

Durham, Benjamin H. ^{[3
]}

Dogan, Ahmet ^{[4
]}

Ozkaya, Neval ^{[4
]}

Lacouture, Mario E. ^{[3
]}

Hajdenberg, Julio ^{[5
]}

Ganzel, Chezi ^{[6
]}

Diamond, Eli L. ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10021 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA

[3] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA

[4] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA

[5] Univ Florida, Hlth Canc Ctr, Orlando Hlth, Gainesville, FL 32611 USA

[6] Shaare Zedek Med Ctr, Dept Hematol, Jerusalem, Israel

来源：

HAEMATOLOGICA | 2018年 / 103卷 / 04期

基金：

美国国家卫生研究院;

关键词：

ERDHEIM-CHESTER DISEASE; LANGERHANS CELL HISTIOCYTOSIS; METASTATIC MELANOMA; SOLID TUMORS; FREE DNA; MUTATION; BRAF; VEMURAFENIB; EFFICACY; TRIAL;

D O I：

10.3324/haematol.2017.185298

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：E177 / E180

页数：4

共 15 条

[1] Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology
Cheng, Donavan T.
Mitchell, Talia N.
Zehir, Ahmet
Shah, Ronak H.
Benayed, Ryma
Syed, Aijazuddin
Chandramohan, Raghu
Liu, Zhen Yu
Won, Helen H.
Scott, Sasinya N.
Brannon, A. Rose
O'Reilly, Catherine
Sadowska, Justyna
Casanova, Jacklyn
Yannes, Angela
Hechtman, Jaclyn F.
Yao, Jinjuan
Song, Wei
Ross, Dara S.
Oultache, Alifya
Dogan, Snjezana
Borsu, Laetitia
Hameed, Meera
Nafa, Khedoudja
Arcila, Maria E.
Ladanyi, Marc
Berger, Michael F.
[J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (03) : 251 - 264
[2] Diamond E L., 2017, JAMA Oncol
[3] Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease
Diamond, Eli L.
Dagna, Lorenzo
Hyman, David M.
Cavalli, Giulio
Janku, Filip
Estrada-Veras, Juvianee
Ferrarini, Marina
Abdel-Wahab, Omar
Heaney, Mark L.
Scheel, Paul J.
Feeley, Nancy K.
Ferrero, Elisabetta
McClain, Kenneth L.
Vaglio, Augusto
Colby, Thomas
Arnaud, Laurent
Haroche, Julien
[J]. BLOOD, 2014, 124 (04) : 483 - 492
[4] Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
Falchook, Gerald S.
Long, Georgina V.
Kurzrock, Razelle
Kim, Kevin B.
Arkenau, Tobias H.
Brown, Michael P.
Hamid, Omid
Infante, Jeffrey R.
Millward, Michael
Pavlick, Anna C.
O'Day, Steven J.
Blackman, Samuel C.
Curtis, C. Martin
Lebowitz, Peter
Ma, Bo
Ouellet, Daniele
Kefford, Richard F.
[J]. LANCET, 2012, 379 (9829) : 1893 - 1901
[5] Reproducible and Sustained Efficacy of Targeted Therapy With Vemurafenib in Patients With BRAFV600E-Mutated Erdheim-Chester Disease
Haroche, Julien
Cohen-Aubart, Fleur
Emile, Jean-Francois
Maksud, Philippe
Drier, Aurelie
Toledano, Dan
Barete, Stephane
Charlotte, Frederic
Cluzel, Philippe
Donadieu, Jean
Benameur, Neila
Grenier, Philippe A.
Besnard, Sophie
Ory, Jean-Paul
Lifermann, Francois
Idbaih, Ahmed
Granel, Brigitte
Graffin, Bruno
Hervier, Baptiste
Arnaud, Laurent
Amoura, Zahir
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (05) : 411 - U52
[6] Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation
Haroche, Julien
Cohen-Aubart, Fleur
Emile, Jean-Francois
Arnaud, Laurent
Maksud, Philippe
Charlotte, Frederic
Cluzel, Philippe
Drier, Aurelie
Hervier, Baptiste
Benameur, Neila
Besnard, Sophie
Donadieu, Jean
Amoura, Zahir
[J]. BLOOD, 2013, 121 (09) : 1495 - 1500
[7] High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses
Haroche, Julien
Charlotte, Frederic
Arnaud, Laurent
von Deimling, Andreas
Helias-Rodzewicz, Zofia
Hervier, Baptiste
Cohen-Aubart, Fleur
Launay, David
Lesot, Annette
Mokhtari, Karima
Canioni, Danielle
Galmiche, Louise
Rose, Christian
Schmalzing, Marc
Croockewit, Sandra
Kambouchner, Marianne
Copin, Marie-Christine
Fraitag, Sylvie
Sahm, Felix
Brousse, Nicole
Amoura, Zahir
Donadieu, Jean
Emile, Jean-Francois
[J]. BLOOD, 2012, 120 (13) : 2700 - 2703
[8] Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
Hauschild, Axel
Grob, Jean-Jacques
Demidov, Lev V.
Jouary, Thomas
Gutzmer, Ralf
Millward, Michael
Rutkowski, Piotr
Blank, Christian U.
Miller, Wilson H., Jr.
Kaempgen, Eckhart
Martin-Algarra, Salvador
Karaszewska, Boguslawa
Mauch, Cornelia
Chiarion-Sileni, Vanna
Martin, Anne-Marie
Swann, Suzanne
Haney, Patricia
Mirakhur, Beloo
Guckert, Mary E.
Goodman, Vicki
Chapman, Paul B.
[J]. LANCET, 2012, 380 (9839) : 358 - 365
[9] Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation
Hervier, Baptiste
Haroche, Julien
Arnaud, Laurent
Charlotte, Frederic
Donadieu, Jean
Neel, Antoine
Lifermann, Francois
Villabona, Carles
Graffin, Bruno
Hermine, Olivier
Rigolet, Aude
Roubille, Camille
Hachulla, Eric
Carmoi, Thierry
Bezier, Maud
Meignin, Veronique
Conrad, Marie
Marie, Laurence
Kostrzewa, Elise
Michot, Jean-Marie
Barete, Stephane
Taly, Valerie
Cury, Karine
Emile, Jean-Francois
Amoura, Zahir
[J]. BLOOD, 2014, 124 (07) : 1119 - 1126
[10] Targeted treatment of brainstem neurohistiocytosis guided by urinary cell-free DNA
Hunt, David
Milne, Paul
Fernandes, Peter
Bigley, Venetia
Collin, Matthew
[J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2017, 4 (01):

← 1 2 →